Manager Management

PAUL M. PALZ, CPA

**** ******* *** ***

Phoenix, AZ. 85083

847-***-**** (e-mail) *****@***.***

Executive Summary

Financial Executive, Planner, Strategist, Facilitator

A distinguished and reputable business professional who has built a strong and diverse background in finance, budgeting, accounting, management and strategic business planning. Specific experience includes treasury management, SEC (including initial public offerings, secondary offerings and related SEC filings), SOX compliance and reporting, business development and divestiture and international and domestic consolidations. Extensive expertise as a business strategist building strategic financial and operational plans with clearly identified and measurable success factors. Motivated team leader, results driven, with outstanding communication, decision-making, analytical and problem resolution skills.

Twenty years of experience in finance, accounting, business operations, management, mentoring and direct communication with Boards, investors, executive management, vendors, auditors, lenders, and consulting firms.

Eighteen years of developing and implementing programs to increase organizational productivity, reduce operational costs and create highly effective and productive work groups/teams.

DETAIL OF BUSINESS EXPERIENCE

Therapeutic Proteins International, LLC. Chicago, Illinois. October 2014 to Present

Bio Pharmaceutical Company developing biosimilar protein products is several therapeutic areas.

Vice President of Finance and Comptroller

Responsible for day-to-day accounting, treasury and working capital management, Board and investor compliance reporting, operations, month-end close activities including consolidation of multiple domestic and international business units and foreign currency translation for this fully integrated manufacturer of biosimilar recombinant protein products in the emerging bio-similar pharmaceutical industry. Report directly to the Chairman of the Board.

Accomplishments:

Fully functionalized existing JDE enterprise system integrating financial modules with purchasing, receiving, manufacturing and reporting modules.

Developed and implemented Board of Directors/Investor reporting and led the re-organization of the senior management team and cost structure of the Company resulting in a reduction in expenditures of over 30%.

Developed and standardized monthly, annual and foreign consolidating financial reports and implemented a financial close and reporting process resulting in timely month end management and Board reporting and external audit support.

Assisted in the FDA filing strategy and commercial launch plan of two product candidates including FDA correspondence, selling and marketing plans, staffing and commercial organization design and compensation structure.

HORIZON PHARMA, INC. Deerfield, Illinois. September 2010 to October 2014

Specialty Pharmaceutical Company commercializing products is several therapeutic areas.

Vice President of Finance and Corporate Controller

Responsible for day-to-day accounting, treasury and working capital management, SEC, Board and investor compliance reporting, operations, month-end close activities including consolidation of multiple domestic and international business units and foreign currency translation for this pharmaceutical company. Report directly to the Chief Financial Officer.

Accomplishments:

Implemented Navision (a Microsoft Dynamics general ledger financial system including planning, selection, installation and data conversion.

Played integral role supporting the CFO in the initial public offering and subsequent secondary offering (S-1 and subsequent SEC reporting) of the Company’s stock

Negotiated, executed and integrated acquisition of products and business (including reverse merger (inversion) of an Irish entity as well as operational integration subsequent to closing of these transactions)

Developed and standardized financials, Board and SEC reporting process resulting in timely month end management and Board reporting, timely filing of SEC Forms 10-Q, 10-K, 8-K, Form 3, Form 4 and other required regulatory reports.

Assisted in the FDA approval and commercial launch of two product candidates including FDA correspondence, selling and marketing plans, staffing and commercial organization design and compensation structure.

DEL GLOBAL TECHNOLOGIES, CORP., Roselle, IL. August 2006 to September 2010

Radiology Equipment Manufacturing Company.

Vice President of Finance and Corporate Controller

Responsible for day-to-day accounting, treasury and working capital management, SEC, Board and investor compliance reporting, operations, month-end close activities including consolidation of multiple domestic and international business units and foreign currency translation for this international radiology manufacturing and distribution company. Reported directly to the Chief Financial Officer.

Accomplishments:

Implemented Microsoft Dynamics (Great Plains) financial and MRP systems including planning, selection, installation and data conversion.

Divested business segment representing over 30% of annual gross revenue, including coordination and planning of transition activities.

Developed and standardized financials, Board and SEC reporting process resulting in timely month end management and Board reporting, timely filing of SEC Forms 10-Q, 10-K and other required regulatory reports.

ESSENTIAL GROUP, INC., Gurnee, IL. August 2004 to August 2006

Drug Clinical Services Company.

Executive Director of Business Finance and Administration

Responsible for day-to-day accounting, operations and all month-end close activities for this drug clinical services company. Responsibilities included management of working capital, billing and treasury management and SEC reporting. Reported directly to the Chief Financial Officer.

Accomplishments:

Project manager over planning, selection and installation of billing-A/R System and Project Accounting/Time and Expense System for new business segment.

Divested business segment representing over 50% of annual gross revenue, including coordination and planning of transition activities.

Developed and implemented standard operating and reporting tools for new business service offering.

KILDEER CONSULTING, Kildeer, IL November 2001 to August 2004

Private Financial and Operational Consulting Group.

Principal Financial and Operational Consultant

Provided financial and operational consulting services and acted in a senior financial capacity for various established and start-up companies. Prepared multi-year business plans, implemented enterprise accounting systems, coordinated conversion of historical data, identified and reported significant business unit profitability and budgets. Also, managed cash and performed controller and treasury duties and negotiated and secured bank financing and SOX compliance reviews.

Accomplishments:

Prepared a 5-year business plan, unit budgeting and full internal and external reporting for a $500,000,000 entity.

Implemented an entire enterprise accounting system including data conversion and report development.

Project manager including installation plan and historical data conversion, for the conversion from Great Plains to Oracle Financial System.

Performed cash management and treasury duties, including the negotiation and securing of bank financing.

Reduced the percentage of delinquent accounts receivables from 30% to 15% of total aging balance reducing DSO from over 40 days to 34 days.

Implemented automated time and expense reporting for consultant operations (12 remote locations) with integrated utilization metrics and automated G/L interface

GENEPROT, INC., Geneva, Switzerland May 2001 to October 2001

Biotechnology Start-up Company.

Corporate Controller

Responsible for day-to-day accounting operations and month-end close process for this biotechnology start-up company. Responsibilities include management of working capital, billing and daily sales reporting, and annual budgeting process. Reported directly to the Chief Financial Officer.

Accomplishments:

Streamlined the month end close process which reduced the close cycle time from quarterly and 95+ days to monthly and 20 days.

Established foreign currency translation and corporate consolidation models and procedures.

Initiated a standard month-end close and financial reporting package.

Developed installation plan for new Oracle Accounting and Reporting software.

ALLSCRIPTS, INC., Livertyville, IL. August 1999 to May 2001

E-commerce, Healthcare Technology Company.

Controller

Responsible for day-to-day accounting operations and month-end close processes, including SEC reporting requirements, for this public, e-commerce company in the healthcare technology industry. Responsibilities included management of working capital, billing and daily sales reporting, as well as annual budgeting. Reported directly to the Senior Vice President of Finance

Accomplishments:

Developed and standardized SEC reporting process resulting in timely filing of SEC Forms 10-Q, 10-K and other required regulatory reports.

Supported the second offering of the Company’s common stock including preparation and printing supervision of the prospectus.

Integrated financial operations of five acquired sites over 12 month period to ensure timely and accurate month-end reporting and elimination of redundant activities

Prepared SEC filings for all acquisitions including preparation of regulatory forms 8-K and related pro forma financial statements and managed coordination of external accountants and legal counsel.

VALENCE RESEARCH, LLC., Chicago, IL. 1997 to 1999

Start-up, Site Management Company.

Director of Finance and Administration

Responsible for implementing financial systems and cash management strategies for this start-up company in the emerging site-management industry. Also responsible for the preparation of operating and capital budgets as well as financial modeling. Assisted in the identification and negotiation of acquisition strategies and venture capital investment opportunities. Supervised partnership/LLC tax and statutory reporting including valuation of equity partner shares. Reported directly to the President and CEO. Valence was divested and subsequently liquidated in 1999.

Accomplishments:

Standardized weekly/monthly financial report distribution resulting in more timely and relevant management decisions and greater visibility of cash flow issues.

Identified over $500,000 in operating savings through software development and equity finance accounting treatments.

Developed business forecasting model used in the equity partner procurement process.

Developed financial model to evaluate the impact of proposed acquisition targets and pro-forma financial impact of said acquisition.

Promoted to Corporate Controller and Chief Compliance Officer for parent company, ArcVentures, to facilitate the divestiture of portfolio business.

SOLOPAK PHARMACEUTICALS, Elk Grove Village, IL. 1996 to 1997

Drug Manufacturing Company.

Plant Controller

Responsible for cost accounting, A/P, operational activity reporting, cash control and banking/investor relations, including capital calls and maintenance of equity accounting for this $70 million drug manufacturer. Managed purchasing and capital asset budgeting and supervised and mentored staff of 9 including 3 managers. Reported directly to the VP of Finance/CFO. Solopak Pharmaceuticals was liquidated in 1997.

Accomplishments:

Implemented internal control system surrounding purchasing and accounts payable resulting in a 30% reduction in orders processed, greater control over spending and a multiple bid process.

Developed and maintained a capital asset tracking system to identify significant over spending of capital projects.

Standardized weekly/monthly financial report distribution resulting in more timely and relevant management decisions.

CAREMARK/BAXTER INTERNATIONAL, Lincolnshire, IL. 1987 to 1996

Mail Order Prescription Distribution Company.

Various Financial Manager and Operational Manager Roles

Consistently promoted over nine year tenure with this $900 million mail order pharmacy. Initially hired and served as the Manager, Financial Reporting from 1987–1992, served as the Manager, Planning and Analysis from 1992-1993, served as Manager, Sales Administration from 1993-1994, and served as the Operations Financial Manager from 1994-1996.

Accomplishments:

Sole financial representative on project identifying $30 million in operational savings for a $400 million division.

Identified over $500,000 in unbilled POS transactions by upgrading systems and correcting procedural deficiencies.

Identified over $4 million in potential operational savings through reorganization of corporate structure.

Supported the divestiture of significant retail service business.

Established SBU reporting structure for operational/financial reporting.

Developed standardized client profitability and cost savings/drug benefit cost model.

Automated budget process for division with over 150 cost centers.

Established standard budget assumptions for pharmacy operations and administration.

Supported the acquisition of a $12 million Retail Drug Claim Processor by valuing acquired assets, recording the financial transactions of the acquisition and determining the tax impact of each.

MICRODOT CORPORATION, Chicago, IL. 1986 to 1987

Manufacturing and Electronics Development Company

Senior Internal Auditor

ARTHUR ANDERSEN & COMPANY, Chicago, IL. 1983 to 1986

Public Accounting Firm

Senior Auditor

EDUCATION & COMPUTER SKILLS

BBA in Accounting, Loyola University, Chicago, Illinois,

Certified Public Accountant, State of Illinois, 1984.

Microsoft Office Suite MS Access Peoplesoft Great Plains Oracle

PROFESSIONAL MEMBERSHIPS

American Institute of CPA’s, Illinois CPA Society, Financial Executives International

Contact this candidate